Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
Imophoron's investors include Octopus Ventures, Global Brain Corporation, SCVC, Jonathan Milner.
Imophoron is headquartered in Bristol, United Kingdom.
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
Imophoron is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Imophoron — Funding & Investors." VCBacked, July 7, 2023, https://www.vcbacked.co/company/imophoron. Accessed August 14, 2026.
VCBacked. (2023). Imophoron — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/imophoron
{{cite web |title=Imophoron — Funding & Investors |url=https://www.vcbacked.co/company/imophoron |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated